ライフサイエンスコーパス: Pharma

1 y qualified vaccine developed outside of big pharma.

2 ncer Foundation, SIAK Switzerland, and Bayer Pharma.

3 h Cancer Foundation; SIAK Switzerland; Bayer Pharma.

4 putational technologies in both academia and pharma.

5 of this review as computational chemists in pharma.

6 and Innovation SERI (Switzerland), and Roche Pharma.

7 o toxicity suggests applications in food and pharma.

8 Acerta Pharma, a member of the AstraZeneca Group, and R35 CA198

9 Acerta Pharma, a member of the AstraZeneca Group.

10 eview Committee (SRC), supported by Novartis Pharma AG, analyzed investigator-reported cases of intra

11 esearch UK, European Union, MRC, NIHR, Bayer Pharma AG, Barbour Foundation.

12 land) versus ranibizumab (Lucentis; Novartis Pharma AG, Basel, Switzerland) for neovascular age-relat

13 sted the effect of everolimus (RAD, Novartis Pharma AG, Basel, Switzerland) on human PTLD-derived cel

14 Roche Pharma AG, Mundipharma, German Federal Ministry of Educa

15 hylated pectin) in development by Archimedes Pharma and CriticalSorb(TM) (polyglycol mono- and dieste

16 Especially discussing their use in the pharma and crop science industries to follow their fate

17 ctional ingredients and has use in the food, pharma and nutraceutical industries.

18 on February 11-16 and sponsored by Astellas Pharma and Regulus Therapeutics.

19 Seagen, Astellas Pharma, and Merck Sharp & Dohme.

20 a), Servier, GlaxoSmithKline, Novartis, King Pharma, and national or local organisations in participa

21 ranostics to inform researchers, clinicians, pharma, and regulators of the potential benefits and eme

22 In contrast to our report on Novartis Pharma APP23 Tg mice, which maintain high levels of solu

23 Research Council GLOBVAC Program and Bionor Pharma ASA.

24 c, and gadolinium-enhanced (Magnevist; Bayer Pharma, Berlin, Germany) magnetic resonance (MR) imaging

25 ility to elucidate mechanisms of action from pharma, biomedicine, analytical chemistry, or toxicology

26 ech; inactivated vaccine) or BNT162b2 (Fosun Pharma-BioNTech; mRNA vaccine).

27 g pro-drugs of propofol such as Aquavan (MGI Pharma, Bloomington, Minnesota, USA) and novel 'soft-dru

28 rse functional groups to nitriles, including pharma building blocks, in high yields using the silane

29 Falk Pharma; CEC-3 EudraCT number, 2017-002241-30.).

30 e processes at various development stages in pharma, classified according to the development phase.

31 ct of lurasidone (Latuda; Dainippon Sumitomo Pharma Co. Ltd., Tokyo, Japan), a newly approved atypica

32 stigate short-term efficacy, pharmacokinetic/pharma- codynamic (PK/PD) relations, and safety of ICL67

33 compounds with better properties than do big pharma companies and universities.

34 in-cleaving enzyme 1 (BACE-1), with many big pharma companies expending great resources in the search

35 ticles has doubled, the output from 23 large pharma companies in the past decade has dropped signific

36 plifies the interest of multi-billion dollar pharma companies worldwide for further developments of S

37 its use by research laboratories, biomedical pharma, companion diagnostic developers, and healthcare

38 Here, experts from a large pharma company and a biotech firm provide their perspect

39 shed parallel high throughput screening of a pharma compound collection against kinetoplastids.

40 ene, Cerevel, Coave, DaCapo Brainscience, 4D Pharma, Denali, Edmond J Safra Foundation, Eli Lilly, GE

41 e natural products-based method of potential pharma discovery is much augmented by the capacities of

42 The patcherBot(Pharma) enables recording from cells expressing receptor

43 Orion Corporation Orion Pharma, Endo Pharmaceuticals Inc.

44 (Myrbetriq extended-release tablet, Astellas Pharma) for 4 weeks in an open-label study.

45 Astellas Pharma Global Development and Seagen.

46 Astellas Pharma Global Development, Basilea Pharmaceutica Interna

47 urrently an employee of Boehringer Ingelheim Pharma GmbH & Co KG.

48 n LLC, King of Prussia, PA, USA; and Centeon Pharma GmbH, Marburg, Germany) is marketed in Europe, So

49 ty (ADMET) data shared across multiple major pharma has been performed.

50 Pharma has responded by embarking on a range of initiati

51 For a range of potential products (fuel to pharma), high lipid productivity strains are required to

52 rces available to scientists working in "big pharma." High costs include those associated with high-t

53 y 2019 until September 2021 sponsored by the Pharma Imaging Network for Therapeutics and Diagnostics

54 019 to October 2021 sponsored by the PINTaD (Pharma Imaging Network for Therapeutics and Diagnostics)

55 Indeed, the power of "Big Pharma" in many medical fields including transplantation

56 nd sodium benzoate therapy (Ammonul, Ucyclyd Pharma) in 299 patients with urea-cycle disorders in who

57 Astellas Pharma Inc, Medivation LLC (a Pfizer Company).

58 Astellas Pharma, Inc and Medivation, Inc.

59 This has caused considerable change in large pharma including how medicinal chemists are trained.

60 preparation (VSL#3, 9 x 10(11) bacteria; CD Pharma India Private Limited, New Delhi, India) (n = 66)

61 olvents compatible with further uses in food/pharma industries demonstrated that RSM constitutes a po

62 Klein et al. discuss the academia-pharma industry gap and its impact on patient care, argu

63 ural ingredients for agro-food, cosmetic and pharma industry uses, as replacements for the synthetic

64 lic acids widely available in Nature and the pharma industry with a great structural diversity occur

65 However, obtaining FDM pharma-ink (drug-loaded filaments) of consistent diamete

66 production method for dimensionally accurate pharma-ink, and second, accomplishing non-destructive do

67 , were accurately printed with the developed pharma-ink, with mass and drug content variations within

68 penta decalactone (azone)) developed by CPEX Pharma, Intravail (alkylsaccharides) developed by Aegis

69 eview is highly pertinent at a time when big pharma is desperately trying to escape flatland drugs.

70 The patcherBot(Pharma) is built using a conventional patch-clamp rig, a

71 s Ltd), Chisys based on chitosan (Archimedes Pharma Ltd) and Intravail based on alkylsaccharides (Aeg

72 ther antioxidant therapy (Antox version 1.2, Pharma Nord, Morpeth, UK) or matched placebo (2 tablets,

73 Many major Pharma now have R&D programmes in this area and in 2013

74 ults indicate the potential of cloudberry in pharma or health food applications.

75 al properties were identified from a Zealand Pharma peptide library using pharmaceutical profiling, e

76 re-S2) recombinant vaccine (Hepacare; Medeva Pharma Plc, Speke, UK).

77 e Olink Explore 3072 assay in the UK Biobank Pharma Proteomics Project (53,018 individuals and 2,920

78 le plasma proteomic data from the UK Biobank Pharma Proteomics Project (UKB-PPP) and AD genome-wide a

79 e plasma proteomics datasets: the UK Biobank Pharma Proteomics Project and deCODE Genetics (4719 prot

80 The Pharma Proteomics Project is a precompetitive biopharmac

81 c peptide], and TNNI3 [troponin I]) from the Pharma Proteomics Project of the UK Biobank cohort (over

82 study summary data from UKB-PPP (UK Biobank Pharma Proteomics Project), CARDIoGRAMplusC4D, and FinnG

83 tion analysis statistics from the UK Biobank Pharma Proteomics Project, including 54,219 participants

84 ion-scale proteomics dataset, the UK Biobank Pharma Proteomics Project, to characterize genetically-d

85 individuals from the United Kingdom Biobank Pharma Proteomics Project, we integrated measurements of

86 g with the patcherBot(Pharma) The patcherBot(Pharma) provides the ability to conduct complex and comp

87 e ability to transverse scales, tolerance of pharma-relevant (hetero)aryls and biorthogonal functiona

88 enges facing the pharmaceutical industry and Pharma's responses to address these challenges.

89 enges facing the pharmaceutical industry and Pharma's responses, focusing on the industry's changing

90 (Enzon Pharmaceuticals, Piscataway, NJ; Skye Pharma, San Diego, CA), an intrathecal (IT) preparation

91 e to cerebral edema deaths during a separate pharma-sponsored trial.

92 the lead on the establishment of a 'virtual pharma' structure, through which researchers will partne

93 ose combination (FDC) tablet (Sovodak, Rojan Pharma, Tehran, Iran).

94 ological electrophysiology robot, patcherBot(Pharma), that substantially improves throughput and redu

95 erator spent interacting with the patcherBot(Pharma) The patcherBot(Pharma) provides the ability to c

96 CIFRE grant from the French Government, HRA-Pharma, the French Ministry of Education and Research, a

97 Lokon Pharma, the Swedish Cancer Society, and the Swedish Rese

98 Because of the growth of "Big Pharma," the relationship between academia and industry

99 In contrast to big pharma, these environments are often more limited in ter

100 ficacy, are critical for partnering with Big Pharma to produce novel therapeutics.

101 The decision of big Pharma to reduce investment from the Neurosciences has h

102 ancer Research UK, Janssen-Cilag, and Chugai Pharma UK.

103 target, at least in the view of many in 'Big Pharma,' 'undruggable' for this indication.

104 he rate of data collection of the patcherBot(Pharma) was a data point every 2.1 minutes that the oper

105 Astellas Global Development Pharma, Washington University Institute of Clinical and